ASCOT-LLA: Anglo-Scandinavian Cardiac Outcomes Trial- Lipid Lowering Arm
PRINCIPAL RESEARCHERS
Björn Dahlöf (University of Gothenburg)
Neil Poulter (Imperial College London, UK)
Peter Sever (Imperial College London, UK)
data cuStodian
ASCOT-LLA Investigators
funding
Pfizer Inc.; Servier Research Group; Leo Laboratories
key publications
- Design paper: J Hypertens 2001; 19: 1139-1147
- Main results: Lancet 2003; 361: 1149–58
- Diabetes: Diabetes Care 2005; 28: 1151-7
- Timing: Am J Cardiol 2005; 96: 39F-44F
- Blood pressure: Eur Heart J 2006; 27: 2982-8
- 2-Year follow-up: Eur Heart J 2008; 29: 499–508
- Central aortic pressures and hemodynamics: Circulation 2009; 119: 53-61
- Augmentation of the carotid pressure waveform: Hypertension 2009; 54: 1009-13
- Blood pressure and lipid lowering: Int J Cardiol 2009; 135: 218-22.
- Antihypertensive therapy: J Hypertens 2009; 27: 947-54
- Ethnic variations: Ethn Dis 2011; 21: 150-7
- 11-Year follow-up: Eur Heart J 2011; 32(20): 2525-32
- Effects by age: J Hypertens 2011; 29(3): 592-9
- Baseline predictors: J Hypertens 2011; 29: 2004-13
- C-reactive protein: Eur Heart J 2012; 33: 486-94
- Plasma renin biomarker: Eur Heart J 2012; 33: 2970-9
- C-reactive protein: J Am Coll Cardiol 2013; 62: 717-29
WEBSITE
Other trial-related materials
Serious Adverse Events in ASCOT Lipid-Lowering Arm — Ascot Study